TAUNS Laboratories,Inc. (TYO:197A)

Revenue by Product

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
In-vitro Diagnostic Pharmaceutical	18.43B	Log In	Log In
In-vitro Diagnostic Pharmaceutical Growth	17.62%	Log In	Log In

Revenue by Geography

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Japan	17.82B	Log In	Log In
Japan Growth	15.79%	Log In	Log In
United Kingdom	90.71M	Log In	Log In
United Kingdom Growth	75.72%	Log In	Log In
Other	524.59M	Log In	Log In
Other Growth	126.80%	Log In	Log In